Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment

Yasushi Kawamata,1 Norio Sugawara,1,2 Masamichi Ishioka,3 Kazutoshi Kubo,4 Katsuji Suzuki,5 Akira Fujii,6 Hanako Furukori,7 Taku Nakagami,8 Norio Yasui-Furukori,1,2 Kazutaka Shimoda1 1Department of Psychiatry, Dokkyo Medical University School of Medicine, Mibu, Japan; 2Department of Neuropsychiatry,...

Full description

Bibliographic Details
Main Authors: Kawamata Y, Sugawara N, Ishioka M, Kubo K, Suzuki K, Fujii A, Furukori H, Nakagami T, Yasui-Furukori N, Shimoda K
Format: Article
Language:English
Published: Dove Medical Press 2021-06-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
Online Access:https://www.dovepress.com/different-attitudes-of-patients-and-psychiatrists-toward-benzodiazepin-peer-reviewed-fulltext-article-NDT
_version_ 1818401104486989824
author Kawamata Y
Sugawara N
Ishioka M
Kubo K
Suzuki K
Fujii A
Furukori H
Nakagami T
Yasui-Furukori N
Shimoda K
author_facet Kawamata Y
Sugawara N
Ishioka M
Kubo K
Suzuki K
Fujii A
Furukori H
Nakagami T
Yasui-Furukori N
Shimoda K
author_sort Kawamata Y
collection DOAJ
description Yasushi Kawamata,1 Norio Sugawara,1,2 Masamichi Ishioka,3 Kazutoshi Kubo,4 Katsuji Suzuki,5 Akira Fujii,6 Hanako Furukori,7 Taku Nakagami,8 Norio Yasui-Furukori,1,2 Kazutaka Shimoda1 1Department of Psychiatry, Dokkyo Medical University School of Medicine, Mibu, Japan; 2Department of Neuropsychiatry, Hirosaki University Graduate School of Medicine, Hirosaki, Japan; 3Department of Psychiatry, Minato Hospital, Hachinohe, Japan; 4Department of Neuropsychiatry, Hirosaki-Aiseikai Hospital, Hirosaki, Japan; 5Department of Psychiatry, Aomori Central Hospital, Aomori, Japan; 6Department of Neuropsychiatry, Mutsu General Hospital, Mutsu, Japan; 7Department of Neuropsychiatry, Kuroishi-Akebono Hospital, Kuroishi, Japan; 8Department of Psychiatry, Nakagami Mental Clinic, Ohdate, JapanCorrespondence: Norio Yasui-FurukoriDepartment of Psychiatry, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, JapanTel +81-28-287-2153Fax +81-28-286-5187Email furukori@dokkyomed.ac.jpBackground: Concern regarding the benefit/risk ratio of the long-term use of benzodiazepines (BDZs) and Z-drugs is increasing. To prevent the risk of dependence in BDZ long-term use, it is essential to understand the attitudes of patients and psychiatrists toward BDZ treatment. The aims of this investigation were to 1) obtain information on patients’ attitudes with long-term BDZ use and their referring psychiatrists’ attitudes toward BDZ treatment, including their perception of the difficulty of reducing the dose of BDZs, and 2) identify discrepancies between patients’ and psychiatrists’ perceptions.Methods: A brief questionnaire was constructed to investigate the attitudes of patients receiving BDZ treatment and their referring psychiatrists. Our sample comprised 155 patients who received BDZ treatment for more than one year and their referring eight psychiatrists. Both the patients and their psychiatrists completed our questionnaire between August 2017 and December 2017.Results: Of the patients, 13% felt that it was more difficult to reduce the dose of BDZs than their referring psychiatrists (type A discrepancy), while 25% felt that it was less difficult (type B discrepancy). In the multivariate logistic regression analysis, the female sex and both the patients’ (“psychotherapy plus BDZs was necessary” and “it was necessary to increase the dose of BDZs”) and psychiatrists’ beliefs (“short-term prescription was justified”) were associated with type A discrepancies. Type B discrepancies were associated with psychiatrists’ beliefs that the patient’s wishes justified the use of BDZs and that the cessation of treatment with BDZs would lead to the deterioration of their rapport with their patients.Conclusion: To overcome the discrepancies in the attitudes of patients and psychiatrists toward the cessation of BDZ treatment, it is necessary to promote patient-centered care involving patient psychoeducation and practice guidelines for the decision-making process. Further studies investigating the promotion of patient-centered care to reduce BDZ use are needed.Keywords: dependence, benzodiazepine receptor agonist, anxiolytics, hypnotics, belief
first_indexed 2024-12-14T07:47:10Z
format Article
id doaj.art-e6fa0737678d4e279fc8f41c81388e66
institution Directory Open Access Journal
issn 1178-2021
language English
last_indexed 2024-12-14T07:47:10Z
publishDate 2021-06-01
publisher Dove Medical Press
record_format Article
series Neuropsychiatric Disease and Treatment
spelling doaj.art-e6fa0737678d4e279fc8f41c81388e662022-12-21T23:10:51ZengDove Medical PressNeuropsychiatric Disease and Treatment1178-20212021-06-01Volume 171927193665857Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine TreatmentKawamata YSugawara NIshioka MKubo KSuzuki KFujii AFurukori HNakagami TYasui-Furukori NShimoda KYasushi Kawamata,1 Norio Sugawara,1,2 Masamichi Ishioka,3 Kazutoshi Kubo,4 Katsuji Suzuki,5 Akira Fujii,6 Hanako Furukori,7 Taku Nakagami,8 Norio Yasui-Furukori,1,2 Kazutaka Shimoda1 1Department of Psychiatry, Dokkyo Medical University School of Medicine, Mibu, Japan; 2Department of Neuropsychiatry, Hirosaki University Graduate School of Medicine, Hirosaki, Japan; 3Department of Psychiatry, Minato Hospital, Hachinohe, Japan; 4Department of Neuropsychiatry, Hirosaki-Aiseikai Hospital, Hirosaki, Japan; 5Department of Psychiatry, Aomori Central Hospital, Aomori, Japan; 6Department of Neuropsychiatry, Mutsu General Hospital, Mutsu, Japan; 7Department of Neuropsychiatry, Kuroishi-Akebono Hospital, Kuroishi, Japan; 8Department of Psychiatry, Nakagami Mental Clinic, Ohdate, JapanCorrespondence: Norio Yasui-FurukoriDepartment of Psychiatry, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, JapanTel +81-28-287-2153Fax +81-28-286-5187Email furukori@dokkyomed.ac.jpBackground: Concern regarding the benefit/risk ratio of the long-term use of benzodiazepines (BDZs) and Z-drugs is increasing. To prevent the risk of dependence in BDZ long-term use, it is essential to understand the attitudes of patients and psychiatrists toward BDZ treatment. The aims of this investigation were to 1) obtain information on patients’ attitudes with long-term BDZ use and their referring psychiatrists’ attitudes toward BDZ treatment, including their perception of the difficulty of reducing the dose of BDZs, and 2) identify discrepancies between patients’ and psychiatrists’ perceptions.Methods: A brief questionnaire was constructed to investigate the attitudes of patients receiving BDZ treatment and their referring psychiatrists. Our sample comprised 155 patients who received BDZ treatment for more than one year and their referring eight psychiatrists. Both the patients and their psychiatrists completed our questionnaire between August 2017 and December 2017.Results: Of the patients, 13% felt that it was more difficult to reduce the dose of BDZs than their referring psychiatrists (type A discrepancy), while 25% felt that it was less difficult (type B discrepancy). In the multivariate logistic regression analysis, the female sex and both the patients’ (“psychotherapy plus BDZs was necessary” and “it was necessary to increase the dose of BDZs”) and psychiatrists’ beliefs (“short-term prescription was justified”) were associated with type A discrepancies. Type B discrepancies were associated with psychiatrists’ beliefs that the patient’s wishes justified the use of BDZs and that the cessation of treatment with BDZs would lead to the deterioration of their rapport with their patients.Conclusion: To overcome the discrepancies in the attitudes of patients and psychiatrists toward the cessation of BDZ treatment, it is necessary to promote patient-centered care involving patient psychoeducation and practice guidelines for the decision-making process. Further studies investigating the promotion of patient-centered care to reduce BDZ use are needed.Keywords: dependence, benzodiazepine receptor agonist, anxiolytics, hypnotics, beliefhttps://www.dovepress.com/different-attitudes-of-patients-and-psychiatrists-toward-benzodiazepin-peer-reviewed-fulltext-article-NDTdependencebenzodiazepine receptor agonistanxiolyticshypnoticsbelief
spellingShingle Kawamata Y
Sugawara N
Ishioka M
Kubo K
Suzuki K
Fujii A
Furukori H
Nakagami T
Yasui-Furukori N
Shimoda K
Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment
Neuropsychiatric Disease and Treatment
dependence
benzodiazepine receptor agonist
anxiolytics
hypnotics
belief
title Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment
title_full Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment
title_fullStr Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment
title_full_unstemmed Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment
title_short Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment
title_sort different attitudes of patients and psychiatrists toward benzodiazepine treatment
topic dependence
benzodiazepine receptor agonist
anxiolytics
hypnotics
belief
url https://www.dovepress.com/different-attitudes-of-patients-and-psychiatrists-toward-benzodiazepin-peer-reviewed-fulltext-article-NDT
work_keys_str_mv AT kawamatay differentattitudesofpatientsandpsychiatriststowardbenzodiazepinetreatment
AT sugawaran differentattitudesofpatientsandpsychiatriststowardbenzodiazepinetreatment
AT ishiokam differentattitudesofpatientsandpsychiatriststowardbenzodiazepinetreatment
AT kubok differentattitudesofpatientsandpsychiatriststowardbenzodiazepinetreatment
AT suzukik differentattitudesofpatientsandpsychiatriststowardbenzodiazepinetreatment
AT fujiia differentattitudesofpatientsandpsychiatriststowardbenzodiazepinetreatment
AT furukorih differentattitudesofpatientsandpsychiatriststowardbenzodiazepinetreatment
AT nakagamit differentattitudesofpatientsandpsychiatriststowardbenzodiazepinetreatment
AT yasuifurukorin differentattitudesofpatientsandpsychiatriststowardbenzodiazepinetreatment
AT shimodak differentattitudesofpatientsandpsychiatriststowardbenzodiazepinetreatment